Grifols

XEMBIFY

Manufacturer:

Grifols

Xembify HCPCS:

J1558

HCPCS Code Descriptor:

Injection, immune globulin (xembify), 100 mg

Category:

J Code

Xembify NDCs:

13533-0810-50, 13533-0810-05, 13533-0810-20, 13533-0810-10

Primary Type:

Immunoglobulin

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Subcutaneous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Xembify:

XEMBIFY is an Immunoglobulin drug manufactured by Grifols and administered via the Subcutaneous route of administration. The J Code: J1558 is aligned to the drug XEMBIFY.

ACCESS PRICING AND MORE BY REGISTERING

J1558 Added Date:

July 1, 2020

J1558 Effective Date:

July 1, 2020

J1558 Termination Date:

HCPCS Active

Xembify billing and coding information can be found through Grifols at the link below:
Xembify patient assistance information can be found through Xembify Connexions at the URL: https://www.xembify.com/en/patients/xembify-connexions
XEMBIFY prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for XEMBIFY. Please check back in a few weeks.